About
| Name | Lawrence Korngut |
| University | |
| Website | |
| Research Keywords | ALS, phase 2 and 3 clinical trials of new therapies for neuromuscular conditions, Principal Investigator of the Neuromuscular Disease Registry |
Roles and Connections
| Primary Role | |
| CAN Connections | |
| Looking For | Accepting undergraduate students, Accepting graduate students, Accepting postdoctoral fellows |
Most Cited Publications
| Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N, "A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy." Neuromuscular disorders : NMD 24,6 (2014 Jun): 482-91 |
| Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, Wilton SB, Williamson T, Gill S, Drogos LL, Smith EE, Vohra S, Hill MD, Thabane L, 2016 Symposium on Registry-Based Randomized Controlled Trials in Calgary., "Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?" Journal of clinical epidemiology 80, (2016 Dec): 16-24 |
| Patten SA, Aggad D, Martinez J, Tremblay E, Petrillo J, Armstrong GA, La Fontaine A, Maios C, Liao M, Ciura S, Wen XY, Rafuse V, Ichida J, Zinman L, Julien JP, Kabashi E, Robitaille R, Korngut L, Parker JA, Drapeau P, "Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis." JCI insight 2,22 (2017 Nov 16): |